Hainan Visum Pharmaceutical Co Ltd announced that it has received $15,000,000 in a round of funding led by Zhejiang Hisoar Pharmaceutical Co., Ltd. on June 29, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.36 CNY | +0.79% | -3.05% | -11.54% |
04-28 | Zhejiang Hisoar Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Hisoar Pharma's Unit Passes German Health Regulator's Inspection | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.54% | 1.4B | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- 002099 Stock
- News Zhejiang Hisoar Pharmaceutical Co., Ltd.
- Hainan Visum Pharmaceutical Co Ltd announced that it has received $15 million in funding from Zhejiang Hisoar Pharmaceutical Co., Ltd.